COMPARATIVE EFFICACY AND SAFETY OF LIXISENATIDE AND INSULIN REGIMENS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
|
作者：
Men, P. [1 ]
Qu, S. [2 ]
Luo, W. [2 ]
Liu, Y. [3 ]
Li, C. [4 ]
Zhai, S. [1 ]
机构：
[1] Peking Univ, Hosp 3, Dept Pharm, Beijing, Peoples R China
[2] IQVIA, Shanghai, Peoples R China
[3] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[4] Sanofi, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.269
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB4
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Pamporis, Konstantinos
    Popovic, Djordje S.
    Stachteas, Panagiotis
    Bougioukas, Konstantinos I.
    Fragakis, Nikolaos
    Rizzo, Manfredi
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3648 - 3661
  • [42] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with insulin therapy
    Taylor, T
    Magner, J
    Krol, A
    Kelley, DE
    DIABETOLOGIA, 1998, 41 : A231 - A231
  • [43] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with insulin therapy
    Kelley, DE
    Magner, J
    Krol, A
    Taylor, T
    DIABETES, 1998, 47 : A89 - A89
  • [44] Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
    Yu, Miao
    Shankar, R. Ravi
    Zhang, Ruya
    Zhang, Ye
    Lin, Jianxin
    O'Neill, Edward A.
    Chen, Guojuan
    Liu, Shu
    Tu, Yingmei
    Engel, Samuel S.
    DIABETES OBESITY & METABOLISM, 2019, 21 (02): : 408 - 411
  • [45] Intensification with Two Different Insulin Analogue Regimens in Type 2 Diabetes Mellitus Inadequately Controlled by Basal Insulin; a Subgroup Analysis from the PREFER Study
    Liebl, Andreas
    Prager, Rudolf
    Kaiser, Marcel
    Bergenstal, Richard
    Kozlovski, Plamen
    Rastam, Jacob
    Gallwitz, Baptist
    DIABETES, 2010, 59 : A152 - A152
  • [46] Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis
    Qiao, Yong-Chao
    Ling, Wei
    Pan, Yan-Hong
    Chen, Yin-Ling
    Zhou, Dan
    Huang, Yan-Mei
    Zhang, Xiao-Xi
    Zhao, Hai-Lu
    ONCOTARGET, 2017, 8 (39) : 66504 - 66515
  • [47] BAYESIAN NETWORK META-ANALYSIS (NMA) TO ASSESS THE RELATIVE EFFICACY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED WITH INSULIN
    Taieb, V
    Paocu, M.
    Schroeder, M.
    Nielsen, A. T.
    Neslusan, C.
    Schubert, A.
    VALUE IN HEALTH, 2015, 18 (07) : A598 - A598
  • [48] Efficacy and Tolerability of Insulin Degludec Versus Other Long-acting Basal Insulin Analogues in the Treatment of Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
    Dong, Zhi-Yuan
    Feng, Ji-Hua
    Zhang, Jian-Feng
    CLINICAL THERAPEUTICS, 2022, 44 (11) : 1520 - 1533
  • [49] CLINICAL EFFICACY AND SAFETY OF INSULIN ASPART COMPARED WITH REGULAR HUMAN INSULIN IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS RECEIVING PRANDIAL INSULIN REGIMEN - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Wojciechowski, P.
    Niemczyk-Szechowska, P.
    Olewinska, E.
    Jaros, P.
    Jurkiewicz, B.
    Skarzynska-Duk, J.
    Mlalecki, M. T.
    Rys, P.
    VALUE IN HEALTH, 2014, 17 (03) : A238 - A238
  • [50] Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials
    Zhang, Xiao-Wen
    Zhang, Xin-Lin
    Xu, Biao
    Kang, Li-Na
    ACTA DIABETOLOGICA, 2018, 55 (05) : 429 - 441
12345